CoChat

Iron Deprivation Affects Drug Susceptibilities of Mycobacteria Targeting Membrane Integrity

Open access
Pal, Rahul, Hameed, Saif, Fatima, Zeeshan · 2015 · Journal of Pathogens

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Multidrug resistance (MDR) acquired by Mycobacterium tuberculosis (MTB) through continuous deployment of antitubercular drugs warrants immediate search for novel targets and mechanisms. The ability of MTB to sense and become accustomed to changes in the host is essential for survival and confers the basis of infection. A crucial condition that MTB must surmount is iron limitation, during the establishment of infection, since iron is required by both bacteria and humans. This study focuses on how iron deprivation affects drug susceptibilities of known anti-TB drugs in Mycobacterium smegmatis , a “surrogate of MTB.” We showed that iron deprivation leads to enhanced potency of most commonly used first line anti-TB drugs that could be reverted upon iron supplementation. We explored that membrane homeostasis is disrupted upon iron deprivation as revealed by enhanced membrane permeability and hypersensitivity to membrane perturbing agent leading to increased passive diffusion of drug and TEM images showing detectable differences in cell envelope thickness. Furthermore, iron seems to be indispensable to sustain genotoxic stress suggesting its possible role in DNA repair machinery. Taken together, we for the first time established a link between cellular iron and drug susceptibility of mycobacteria suggesting iron as novel determinant to combat MDR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2015/938523

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Assessment of mycobacterial growth in response to iron deprivation. (a) Drug susceptibility assays against M. smegmatis in the presence of 2,2, BP. Left panel shows broth microdilution assay to determine the MIC80 of M. smegmatis in the presence of 2,2, BP. The minimum drug concentration that inhibits growth by 80% relative to the drug-free growth control is indicated as MIC80. Right panel shows spot assay of M. smegmatis in the absence (control) and the presence of subinhibitory concentration of 2,2, BP (35 μg/mL). (b) Growth curve of M. smegmatis in the presence of 35 μg/mL 2,2, BP.
Figure 1 Assessment of mycobacterial growth in response to iron deprivation. (a) Drug susceptibility assays against M. smegmatis in the presence of 2,2, BP. Left panel shows broth microdilution assay to determine the MIC80 of M. smegmatis in the presence of 2,2, BP. The minimum drug concentration that inhibits growth by 80% relative to the drug-free growth control is indicated as MIC80. Right panel shows spot assay of M. smegmatis in the absence (control) and the presence of subinhibitory concentration of 2,2, BP (35 μg/mL). (b) Growth curve of M. smegmatis in the presence of 35 μg/mL 2,2, BP.CC BY · PubMed Central
Figure 2 Drug susceptibility assays against M. smegmatis in response to iron deprivation. (a) Broth microdilution to determine the MIC80 of M. smegmatis in the presence of EMB, INH, and RIF (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) alone and in the presence of 2,2, BP, DFO, and BPS (35 μg/mL, 656 μg/mL, and 386 μg/mL), respectively, to determine the effect of iron deprivation on susceptibilities of EMB, INH, and RIF. Data was quantitatively displayed with color (see color bar in left panel), where each shade of color represents relative optical densities of the cell and as bar graphs (see right panel). The minimum drug concentration that inhibits growth by 80% relative to the drug-free growth control is indicated as MIC80 for each drug. (b) Spot assays of M. smegmatis in the presence of EMB, INH, and RIF (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) alone and in the presence of 2,2, BP, DFO, and BPS (35 μg/mL, 656 μg/mL, and 386 μg/mL) to confirm the effect of iron deprivation on susceptibilities of EMB, INH, and RIF.
Figure 2 Drug susceptibility assays against M. smegmatis in response to iron deprivation. (a) Broth microdilution to determine the MIC80 of M. smegmatis in the presence of EMB, INH, and RIF (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) alone and in the presence of 2,2, BP, DFO, and BPS (35 μg/mL, 656 μg/mL, and 386 μg/mL), respectively, to determine the effect of iron deprivation on susceptibilities of EMB, INH, and RIF. Data was quantitatively displayed with color (see color bar in left panel), where each shade of color represents relative optical densities of the cell and as bar graphs (see right panel). The minimum drug concentration that inhibits growth by 80% relative to the drug-free growth control is indicated as MIC80 for each drug. (b) Spot assays of M. smegmatis in the presence of EMB, INH, and RIF (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) alone and in the presence of 2,2, BP, DFO, and BPS (35 μg/mL, 656 μg/mL, and 386 μg/mL) to confirm the effect of iron deprivation on susceptibilities of EMB, INH, and RIF.CC BY · PubMed Central
Figure 3 Effect of iron supplementation on reversion of drug susceptibilities. Spot assays of iron deprived cells (2,2, BP, DFO, and BPS) at concentrations of 35 μg/mL, 656 μg/mL, and 386 μg/mL showing hypersensitivity with EMB, INH, and RIF and upon iron supplementation (FeCl3) of 0.2 mM for 2,2, BP, 0.3 mM for BPS, and 0.4 mM for DFO showing rescuing of the drug susceptibilities of EMB, INH, and RIF (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL).
Figure 3 Effect of iron supplementation on reversion of drug susceptibilities. Spot assays of iron deprived cells (2,2, BP, DFO, and BPS) at concentrations of 35 μg/mL, 656 μg/mL, and 386 μg/mL showing hypersensitivity with EMB, INH, and RIF and upon iron supplementation (FeCl3) of 0.2 mM for 2,2, BP, 0.3 mM for BPS, and 0.4 mM for DFO showing rescuing of the drug susceptibilities of EMB, INH, and RIF (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL).CC BY · PubMed Central
Figure 4 Effect of iron deprivation on cell membrane. (a) Nitrocefin membrane permeability assay for M. smegmatis cells grown in the absence (control) and the presence of 2,2, BP (35 μg/mL). Means of O.D485 ± SD of three independent sets of experiments are depicted on y-axis with respect to time (minutes) on x-axis (P < 0.05). (b) Spot assay of M. smegmatis in the absence (control) and the presence of 2,2, BP (35 μg/mL) and cell membrane perturbing agent (SDS) at 0.025%.
Figure 4 Effect of iron deprivation on cell membrane. (a) Nitrocefin membrane permeability assay for M. smegmatis cells grown in the absence (control) and the presence of 2,2, BP (35 μg/mL). Means of O.D485 ± SD of three independent sets of experiments are depicted on y-axis with respect to time (minutes) on x-axis (P < 0.05). (b) Spot assay of M. smegmatis in the absence (control) and the presence of 2,2, BP (35 μg/mL) and cell membrane perturbing agent (SDS) at 0.025%.CC BY · PubMed Central
Figure 5 TEM images under iron deprivation. (a) TEM images for M. smegmatis cells grown in the absence (control) of 2,2, BP (35 μg/mL) and drugs EMB, INH, and RIF with subinhibitory concentrations (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) alone showing smooth cell envelope. (b) TEM images for M. smegmatis cells grown in the presence of drugs (EMB, INH, and RIF) with subinhibitory concentrations (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) along with 2,2, BP (35 μg/mL) showing tampered and elongated morphology.
Figure 5 TEM images under iron deprivation. (a) TEM images for M. smegmatis cells grown in the absence (control) of 2,2, BP (35 μg/mL) and drugs EMB, INH, and RIF with subinhibitory concentrations (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) alone showing smooth cell envelope. (b) TEM images for M. smegmatis cells grown in the presence of drugs (EMB, INH, and RIF) with subinhibitory concentrations (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) along with 2,2, BP (35 μg/mL) showing tampered and elongated morphology.CC BY · PubMed Central
Figure 6 Passive diffusion in response to iron deprivation. (a) Passive diffusion displayed by extracellular concentrations of EtBr for M. smegmatis cells grown in the absence (control) and the presence of 2,2, BP (35 μg/mL) as described in Section 2. Means of O.D285 ± SD of three independent sets of experiments are depicted on y-axis with respect to time (minutes) on x-axis (∗ depicts significant difference with P < 0.05). (b) Passive diffusion displayed by extracellular concentrations of EtBr for M. smegmatis cells grown in RIF alone (control) and in the presence of 2,2, BP (35 μg/mL) as described in Section 2. Means of O.D285 ± SD of three independent sets of experiments are depicted on y-axis with respect to time (minutes) on x-axis (∗ depicts significant difference with P < 0.05).
Figure 6 Passive diffusion in response to iron deprivation. (a) Passive diffusion displayed by extracellular concentrations of EtBr for M. smegmatis cells grown in the absence (control) and the presence of 2,2, BP (35 μg/mL) as described in Section 2. Means of O.D285 ± SD of three independent sets of experiments are depicted on y-axis with respect to time (minutes) on x-axis (∗ depicts significant difference with P < 0.05). (b) Passive diffusion displayed by extracellular concentrations of EtBr for M. smegmatis cells grown in RIF alone (control) and in the presence of 2,2, BP (35 μg/mL) as described in Section 2. Means of O.D285 ± SD of three independent sets of experiments are depicted on y-axis with respect to time (minutes) on x-axis (∗ depicts significant difference with P < 0.05).CC BY · PubMed Central
Figure 7 Indispensability of iron to sustain genotoxic stress. Spot assay of M. smegmatis in the absence (control) and the presence of 2,2, BP (35 μg/mL) and DNA damaging agent (EtBr) at 13 μg/mL.
Figure 7 Indispensability of iron to sustain genotoxic stress. Spot assay of M. smegmatis in the absence (control) and the presence of 2,2, BP (35 μg/mL) and DNA damaging agent (EtBr) at 13 μg/mL.CC BY · PubMed Central
Figure 8 Drug susceptibility assay under alkaline pH. Spot assay of M. smegmatis in the absence and the presence of drugs EMB, INH, and RIF (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) at physiological and alkaline pH 10.
Figure 8 Drug susceptibility assay under alkaline pH. Spot assay of M. smegmatis in the absence and the presence of drugs EMB, INH, and RIF (62.5 ng/mL, 1 μg/mL, and 62.5 ng/mL) at physiological and alkaline pH 10.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. 2014, International Journal of Current Microbiology and Applied Sciences, 3, 528

Cited by

See all 31

Metadata

Authors
Pal, R., Hameed, S., & Fatima, Z.
Affiliations
Amity University Gurugram (IN)
Corresponding author
Fatima, Zeeshan
Venue
Journal of Pathogens
Publisher
Wiley
Published
2015
Volume
2015
Pages
1-10
ISSN
  • 2090-3057 (ISSN-L)
  • 2090-3065
OpenAlex
W2263362631
Cited by
30
References
29
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2020: 2 · 2019: 4 · 2018: 7 · 2017: 3 · 2016: 4
FWCI
3.63
Type
journal article
Language
en
Open access
Locations
  • Journal of Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Science and Engineering Research Board (SR/FT/LS-173/2010, 2013/37B/45/BRNS/1903)
  • Board of Research in Nuclear Sciences (SR/FT/LS-173/2010, 2013/37B/45/BRNS/1903)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Keywords
iron starvation, Mycobacterium tuberculosis, Mycobacterium smegmatis, multidrug resistance, drug sensitivity, membrane integrity, membrane permeability, genotoxic stress, DNA repair, iron supplementation, antitubercular agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.